Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.
about
Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: impact on stem cell harvesting and engraftment.Multiple myeloma in the older adult: better prospects, more challenges.Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trialsMyeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma.High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Autologous stem cell transplantation beyond 60 years of age.Relevant prognostic features of multiple myeloma and the new International Staging System.Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols.Poor outcomes for IgD multiple myeloma patients following high-dose melphalan and autologous stem cell transplantation: a single center experience.Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.Association between complete response and outcomes in transplant-eligible myeloma patients in the era of novel agents.Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study.BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma.High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
P2860
Q33376918-BBEDFE8B-747B-4B62-806A-1E17633A08B9Q34031129-E20171D9-9D68-4473-AF36-42324D57FF97Q34172071-F70F5AFA-88CF-455F-8F03-15603260A807Q34656801-BBC422CD-A403-40B3-B9D4-71EE27C436DFQ35920754-490EF92B-5C86-4A61-B879-D79000C6D993Q36407446-7A5CAEB9-365E-4B2F-B567-20B4DF4596A5Q36623644-8C0D75D1-FC85-4155-9E2B-5C4617C40126Q36799829-90021700-E535-475C-80A2-8D7F494872E8Q36818208-7BA125DF-F229-4E8B-9F14-AD17A3FD7763Q36966074-32419EBC-6D50-4BC1-8DCF-D500D4DD1DEBQ37303841-327B2CDE-A6B1-4213-8DE8-C0855476639CQ40469944-2108FC87-30C0-4FA3-9918-EBE0C4CBC5D3Q45287020-66458573-6B78-4011-AB63-39A15E6CE028Q46127672-8164EE99-23A7-4DF7-9546-891282C64AF5Q53206127-CAEAC6C8-0AD4-4ED7-A151-51A005F7AD4AQ53259579-1C9B8B65-4674-4BB6-968B-6BD9A9C41B8B
P2860
Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Prognostic factors for surviva ...... 133 multiple myeloma patients.
@en
Prognostic factors for surviva ...... 133 multiple myeloma patients.
@nl
type
label
Prognostic factors for surviva ...... 133 multiple myeloma patients.
@en
Prognostic factors for surviva ...... 133 multiple myeloma patients.
@nl
prefLabel
Prognostic factors for surviva ...... 133 multiple myeloma patients.
@en
Prognostic factors for surviva ...... 133 multiple myeloma patients.
@nl
P2093
P2860
P356
P1476
Prognostic factors for surviva ...... 133 multiple myeloma patients
@en
P2093
Krivanova A
Svobodnik A
Vorlicek J
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704728
P407
P577
2005-01-01T00:00:00Z